SHORT REPORT

Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

M W Beresford¹, R Primhak², N V Subhedar¹ and N J Shaw¹

¹ Royal Liverpool Children's NHS Trust, Alder Hey, UK
² Sheffield Children's Hospital NHS Trust, UK

Correspondence to:
Correspondence to:
Dr N J Shaw, Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK;
ben.shaw{at}lwh-tr.nwest.nhs.uk

In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.

Keywords: fluticasone; chronic lung disease; double blind; randomised

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Fantoms

Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2002 87: F2. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Kohler, D., Haidl, P., Dellweg, D., Bont, L., Kimpen, J. L.L., Ermers, M. J.J., Baraldi, E., Filippone, M., Guilbert, T., Martinez, F. D., Szefler, S. J., the Childhood Asthma Research and Education (CARE), , Bisgaard, H., Gold, D. R., Fuhlbrigge, A. L. (2006). Inhaled corticosteroids and children.. NEJM 355: 624-624 [Full Text]  
• Dugas, M.-A., Nguyen, D., Frenette, L., Lachance, C., St-Onge, O., Fougeres, A., Belanger, S., Caouette, G., Proulx, E., Racine, M.-C., Piedboeuf, B. (2005). Fluticasone Inhalation in Moderate Cases of Bronchopulmonary Dysplasia. Pediatrics 0: peds.2004-0951v1-572 [Abstract] [Full Text]